Chang-Li Wang Selected Research

Chang-Li Wang Research Topics

Disease

13	Neoplasms (Cancer) 03/2022 - 05/2009
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021 - 12/2007
10	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2009
5	Neoplasm Metastasis (Metastasis) 10/2017 - 05/2009
3	Adenocarcinoma of Lung 03/2022 - 09/2016
2	Carcinogenesis 03/2022 - 10/2013
2	Lymphatic Metastasis 06/2015 - 10/2013
1	Circulating Neoplastic Cells 10/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Morphine Dependence 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 09/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2016
1	Stomach Neoplasms (Stomach Cancer) 10/2013
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2013
1	Adenocarcinoma 04/2013
1	Malignant Mesothelioma 01/2012
1	Inflammation (Inflammations) 05/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 06/2021 - 10/2013
3	Messenger RNA (mRNA)IBA 03/2022 - 10/2013
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2013
3	ErbB Receptors (EGF Receptor)IBA 10/2020 - 01/2019
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 12/2012
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 09/2009
3	Gefitinib (Iressa)FDA Link 11/2014 - 08/2009
2	Long Noncoding RNAIBA 03/2022 - 01/2020
2	ParaffinIBA 01/2022 - 10/2013
2	CytokinesIBA 01/2022 - 01/2019
2	Peptides (Polypeptides)IBA 10/2020 - 01/2019
2	OsteopontinIBA 04/2015 - 12/2013
1	Biological ProductsIBA 03/2022
1	Untranslated RNA (Noncoding RNA)IBA 03/2022
1	LigandsIBA 01/2022
1	CXC ChemokinesIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Small Interfering RNA (siRNA)IBA 06/2021
1	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 06/2021
1	AntibodiesIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	LipidsIBA 10/2020
1	CarcinogensIBA 03/2020
1	Oncogene Proteins (Oncogene Protein)IBA 03/2020
1	UbiquitinIBA 03/2020
1	n-dodecaneIBA 01/2020
1	lavender oilIBA 01/2020
1	Pemetrexed (MTA)FDA Link 01/2020
1	CatecholaminesIBA 01/2020
1	EstersIBA 01/2020
1	PlatinumIBA 01/2020
1	Serotonin (5 Hydroxytryptamine)IBA 01/2020
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2020
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2020
1	Ammonium CompoundsIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Gemcitabine FDA Link 01/2019
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2019
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2019
1	AntigensIBA 01/2019
1	CalciumIBA 01/2019
1	Terfenadine (Seldane)IBA 10/2017
1	Taxoids (Taxanes)IBA 10/2017
1	Epirubicin (Ellence)FDA LinkGeneric 10/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2016
1	RNA (Ribonucleic Acid)IBA 09/2016
1	Claudin-1IBA 09/2016
1	puerarinIBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2016
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 04/2016
1	SolutionsIBA 04/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016
1	AlkaloidsIBA 01/2016
1	icotinibIBA 11/2014
1	IntegrinsIBA 12/2013
1	StathminIBA 10/2013
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 04/2013
1	Activating Transcription Factor 2IBA 04/2013
1	Mitogen-Activated Protein KinasesIBA 04/2013
1	ClaudinsIBA 04/2013
1	Epidermal Growth Factor (EGF)IBA 12/2012
1	Cetuximab (Erbitux)FDA Link 12/2012
1	SuspensionsIBA 12/2012
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2012
1	Radiation-Sensitizing AgentsIBA 08/2009
1	ChemokinesIBA 05/2009
1	CCR1 ReceptorsIBA 05/2009

Therapy/Procedure

4	Therapeutics 01/2021 - 06/2018
2	Neoadjuvant Therapy 01/2021 - 01/2019
2	Immunotherapy 01/2021 - 06/2018
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2019
2	Pneumonectomy (Lung Volume Reduction) 12/2012 - 12/2007
2	Adjuvant Chemotherapy 12/2012 - 12/2007
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020
1	Lymph Node Excision (Lymph Node Dissection) 10/2018
1	Precision Medicine 01/2017
1	Subcutaneous Injections 04/2016
1	Radiotherapy 06/2015